The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine

Front Pharmacol. 2023 Apr 21:14:1151196. doi: 10.3389/fphar.2023.1151196. eCollection 2023.

Abstract

Ischemic stroke (IS) is the second leading cause of death and disability in the world. Pyroptosis, a form of programmed cell death initiated by caspases, participates in the occurrence and development of IS. Because it can increase cell membrane permeability, mediate the release of inflammatory factors, and aggravate inflammation, inhibiting this process can significantly reduce the pathological injury of IS. The nucleotide binding oligomerization domain-like receptor family pyrin domain protein 3 (NLRP3) is a multiprotein complex whose activation is the core link of pyroptosis. In recent years, studies have reported that traditional Chinese medicine (TCM) could regulate pyroptosis mediated by NLRP3 inflammasome through multi-channel and multi-target networks and thus exert the effect against IS. This article reviews 107 papers published in recent years in PubMed, Chinese National Knowledge Infrastructure (CNKI), and WanFang Data in recent years. It has found that the activation factors of NLRP3 inflammasome include ROS, mitochondrial dysfunction, K+, Ca2+, lysosome rupture, and trans-Golgi breakdown. TLR4/NF-κB/NLRP3, ROS/TXNIP/NLRP3, AMPK/Nrf2/NLRP3, DRP1/NLRP3, TAK1/JNK/NLRP3 signaling pathways regulate the initiation and assembly of the NLRP3 inflammasome, subsequently induce pyroptosis, affecting the occurrence and development of IS. TCM can affect the above signaling pathways and regulate the pyroptosis mediated by NLRP3 inflammasome, so as to play a protective role against IS, which provides a new entry point for discussing the pathological mechanism of IS and a theoretical basis for developing TCM treasure house.

Keywords: NLRP3; ischemic stroke (IS); pathways; pyroptosis; traditional Chinese medicine (TCM).

Publication types

  • Review

Grants and funding

This work was supported by State Key Laboratory Open Program of China (GTZK201711), Hunan Provincial Natural Science Foundation of China (2020JJ9050), Double-class Discipline Pharmacy Open Fund of China (2018YX03), Hunan Provincial Department of Education Postgraduate Innovation and Entrepreneurship Training Program Project of China (CX20220794), Innovation and Entrepreneurship Training Program for College Students of Hunan Provincial Department of Education of China (S202210541074), First-class undergraduate courses in Hunan Province of China (2021(28)-371) and Research project of educational reform in universities in Hunan Province of China (HNJG-2022-0134).